Flurbiprofen

(Preusmjereno sa stranice ANSAID)

Flurbiprofen (po IUPACu 2-(3-fluoro-4-fenil-fenil)propionska kiselina) spada u grupu nesteroidnih antiupalnih lijekova. Hemijska formula mu je C15H13FO2. Spada u porodicu derivata fenilalkanoične kiseline. Upotrebljava se za ublažavanje upale i bola kod artritisa.[5][6] Također je poznat po trgovačkom imenu ANSAID kojeg proizvodi farmaceutska kompanija Pfizer.

Flurbiprofen
Klinički podaci
Robne marke Adfeed, Ansaid, Antadys, Apo-Flurbiprofen
AHFS/Drugs.com Monografija
Identifikatori
CAS broj 5104-49-4
ATC kod M01AE09 , S01BC04
PubChem[1][2] 3394
DrugBank DB00712
ChemSpider[3] 3277
ChEBI CHEBI:5130 DaY
ChEMBL[4] CHEMBL563 DaY
Hemijski podaci
Formula C15H13FO2 
Mol. masa 244,261
SMILES eMolekuli & PubHem
Fizički podaci
Tačka topljenja 110-111 °C (-58 °F)
Farmakokinetički podaci
Poluvreme eliminacije 4,7 h
Izlučivanje Renalno
Farmakoinformacioni podaci
Trudnoća ?
Pravni status
Način primene Oftalmički, oralno

R-flurbiprofen je jedini enantiomer flurbiprofena. Ovaj spoj se trenutno ispituje za upotrebu prilikom tretmana metastatičkog raka prostate i Alzheimerove bolesti.

Flurbiprofen je organsko jedinjenje, koje sadrži 15 atoma ugljenika i ima molekulsku masu od 244,261 Da.

Osobine

uredi
Osobina Vrednost
Broj akceptora vodonika 2
Broj donora vodonika 1
Broj rotacionih veza 3
Particioni koeficijent[7] (ALogP) 3,7
Rastvorljivost[8] (logS, log(mol/L)) -4,6
Polarna površina[9] (PSA, Å2) 37,3

Reference

uredi
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  5. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.  edit
  6. David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.  edit
  7. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  8. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.  edit
  9. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.  edit

Literatura

uredi

Vanjske veze

uredi